Additionally, ORO staining revealed that, compared with the other treatments, the combination of STARD4 overexpression and enzalutamide treatment resulted in a significant reduction in LD size within tumour tissues (Fig. 8H, S7F). This evidence concerns the gene STARD4 and neoplasm.